Member Info for drshan

Does this suggest that the Twatter is still in the relentless, remorseless pursuit of - ANY - kernel of negativity to explore?

LOL.... day in day out, minions in tow... relentless, cynical. Oh, but they're invested! What a way to make a living, live life...... urrgh, got some upchuck on the Church's, damn.

Oh, please do FO you self aggrandising Twatter. It causes a physical twinge of pain reading your self-serving crap, day in, day out. Thankfully, I quickly come to my senses and self edit your manipulative drivel, thereby avoiding any lasting damage. A drivel aversion.

C'mon, let's have your usual snide, self-important and ever so snarky response!

"bline59 is doing free Bullshido (bull$h it) courses" necessary for your Twatter minion application. But still people fall for it, and, LSE allow it, day in, day out!

Actually, has everything to do with LFT's. Accurate, reliable LFT's of modest cost are a potential godsend for many sectors, i.e. aviation, and an LFT will not flag your prospective traveller as positive because they had Covid last month.

Think some of you guy's need to back track and re-read the post from Northenhero and response from Mr Rhubarb. He answers a query from NH, dealing with a past scenario, then pivots to the current situation. It is clear if you look at the Q&A of the thread and pay attention to the context. No duplicitous BOD buy out strategies going on, so y'all can stand down - back to def-con 5.

Don't want the nervy jumping to rash conclusions, do we? Or do we.....

"Be honest how upset was gerry when the CR fell threw"

Let's 'be' honest. How daft do you look with your crappy punctuation, awful spelling, dire grammar and general lack of credibility.

Was Gerry upset? How prescient of you. A glimpse into a possible future where apparent stupidity necessitates you leave the board in disgrace as all tolerance of the dim of wit, finally, thankfully, fell threw (sic).

Hey Chesh. What a bore eh! What a chore..... axe to grind.... Urrgh.

I think it has to be said, given the sentiment embodied in the OP musings which revolve around share price appreciation or lack thereof (understandable), is an acknowledgement that whilst it would be very nice to realise a great return on investment, I would be happy if Suzy and board made any reasonable deal that drew a line under this period, these drug candidates, gave them the financing and opportunity to progress future candidates, and moves any of the existing portfolio forward, toward a productive future helping people.
If they wipe their face and I make a small profit, I'll be happy. Not a popular point of view I'm sure, but the name of the game is survival, stay in the game, keep doing the work, developing new prospects. This group is long in the tooth, get any of them out of the door, bank some cash - move on.

Sam, you beat me to it.

I had written:
Not sure if I agree. Physiomics had just 1M cash at hand, earned 800,000 (2020) and made a net 60k loss (2020).
I don't believe for a second that they would commit more than 200k in costs to evaluate the candidates, any more exposes them to significant risk.
Costs, of course, are manpower, plus material, plus overheads.

I'm feel for you, that must be one of the weakest, most lame, responses I've had the misfortune to read. Muggy would be appalled.

It deserves no reply, can't do it, nope. Too much.

"Only one of those companies r&d expenses are in the 10s of millions each"

What does that have to with the price of fish? Anything?

Estée Lauder, Unilever alone are monsters, massive companies, how is their R&D spend remotely relevant? I'll tell you, help you out....it isn't.

I reported the muppet Rat.

This person continually ignores reasonable debated points, and insists on bullying people around demonstrably factual, established points. In this instance, he implies the company is being untruthful about its involvement with 18 companies involved in healthcare. The company has established contracts for lab services in place, yielding revenue with these companies..... He turns up to misinform, disrupt, de-ramp. He's not a shareholder, he's a manipulator.

Urggh! hadn't realised whilst writing that, the GWoods/Muggins crew had arrived for some concerted de-ramping.....geez.

sipps, David,

great contributions. Thank you. Really well-rounded overview and so much more detail than I could either be bothered to collate or find the time to write.

To add to the why/utility element of STC. Dermatologists are to some degree limited in what they can achieve from inspection/observation; it is not possible to account for genetic heritage/undiagnosed allergen sensitivity/non beneficial bacterial contamination from mere observation, all of which I believe can be encompassed in the STC sampling; this why DVRG are receiving interest from dermatologists, it gives them access to an additional, useful diagnostic tool with demonstrable utility.

Ingredients in many cosmetics, both natural and synthetic, can have a significant deleterious effect on skin health (especially true of cheaper formulations) as can elements (favoured by ladies in particular)such as perfumes, as an example.
In years gone by, many ostensibly 'high-end' cosmetics companies produced products laced with perfumes, both synthetic and natural and called their so-called products claimed to be hypo-allergenic; they regularly had customers complaining bitterly that their expensive product had caused all manner of problems; acne; rashes etc
Lanolin is a common low-cost ingredient that many skins fail to tolerate; people use these products for years, flopping around from one inappropriate product to another, not understanding what is at the root of their problem.

This then (hopefully) gives you a little insight into the potential utility of the product STC is offering to the lay person; It facilitates you making better choices in selecting skin care products that exclude the ingredients that the science says you should avoid, for your particular skin type and microbiome makeup.

Hope that illuminates things for ya!

As I'd bothered to write a response to those of you that responded, I'll post it here and say, thank you, for taking the trouble. I guess we can all see now that, yes, dissent of the status quo will not be tolerated, and that this is the price of a free BB. A worthless, shill forum.

Ok chaps, (prob sexist, assumptive I know) great well-balanced and informed responses that illuminate the (my) perceived problem here.

I take on board all points made and am pleased that for once, it seems reasonable and balanced. I, like many here, have been reading periodically the various musing presented over almost a year and half now, and the constants that have stood out most starkly and damningly (as far as my general conclusions toward the relative utility of this LSE BB as a forum for the useful exchange of ideas, theories, research etc) have I suppose, to an unfortunate degree, been coloured by the relentless professional/employed posters who are here, week in week out, seemingly untouchable, pouring out a constant stream of negativity, it's galling to witness and even more unpleasant to read/navigate.

As far I'm concerned, (though all views are considered) LSE need to moderate with an eye on context/intention/narrative, because giving a 'pass' to the accomplished manipulator/s to push and pull sentiment to satisfy their agenda is manifestly NOT what these BB are for; and I, do not believe that that would be what most casual investors, coming here to garner useful information, would imagine they are for either.

Dissemination of pertinent and salient information - YES

Manipulation of sentiment and consequently of the share price through never ending stream of disinformation and sometimes down right lies - NO

So there we go, last word on it.

Yawn..... show me the money.... at the moment I'm pinning my hopes on STC.

Cost of entry low, regional infrastructure compact, keeping costs low, cost of global of roll-out low, margins high (presumably), additional added value of burgeoning data bank - high - and saleable/licensable, IP moat - large, short to medium term positive cash generation potential - high.

Let's see what the CR deal means for us all. Hopefully we will get a clear view of what they are cooking up.
Been reading all of this material for months; the day I see a reference to our darling little company, I will no doubt spew my tea across the room.

Retrofit of microtox PD is great and will bolster revenues, both immediate and moving forward, but some new contract wins would go a long way to consolidate and underpin the MW takeover, another priority, surely. I guess GB would say the imminent deal with CR is the catalyst and I suppose we'll see if the provinces have been given budgets by Beijing, to pay for testing/monitoring infrastructure. If so, game on.

Keep posting the links, but help me out and tell me if it has no mention of DVRG, so I can (almost certainly) choose to not bother; read so many, can't be arsed with any more.

Isn't it quiet, it's somewhat disconcerting. LOL

LOL - your very funny Mr Rhubarb - a classic

Overall very good.

Microtox PD/BT

Have to say disappointed RE: Microtox BT and how that was touted back in late 2020, the expectations that were given to shareholders and the subsequent morphing into something quite different and long term; I understand why, I see the long term value of why GP's surgeries, broader application of multi pathogen detection etc, just feel very/a little misled, GERARD!
PD sounds really terrific and a tremendous description from 'yer man' Finn. A lot of emphasis on China, great if it pans out as the numbers bandied are eye watering, slight reservations around the costs with regard to take up for other jurisdictions (Europe, USA, everywhere else) as new contracts since the beginning of the year have been.... ahh, let's say thin. Perhaps the new fangled AI based PD kit will drive some global sales, inspire some iphone (tech-savvy, forward-thinking) using, cashed up, decision makers to take the plunge. It makes sense, it's real time analysis, what's not to like. Oh yeah, It cost loads!

The JV with China Resources. I want to see detail ASAP. Investors have a right to know what the financial terms of this deal will mean for us. The mood music sounds great, the proposed production capacity, the near term demand from the provinces; all sounds go, go, go - if a little, "you get to eat this jam sandwich tomorrow". I wanna see the detail, and so should you.

STC/Labskin

Yay, Android - big positive. Expanding capacity here to 20,000 p/m and USA the same capacity near-ish term, through an existing partner, though China back end of 2022 - Boo! - great stuff overall. The prospect of significant earnings in the short to midterm seem very possible and tangible now - income generation, horrah!

I'm still positive, I can see there is a lot happening, that the focus on income generation is being emphasised and this bodes well for the future if it can be realised. Best of luck to the whole team at DVRG and congratulations, for the hard work invested, and the progress achieved thus far.

My view (clearly) if you don't like..... you know what to do..... actual work to do now so..... and if I made factual errors/spelling, slips in grammar that upset some, this was of the cuff, from memory, no more blether time.

Now that, dear Muggy, I can agree with. He's sloppy on detail, cavalier with statements, but when you turn up, on cue, every single time you see an opportunity to do as much damage as possible with your 'very' selective statements, all I can say to you in good conscience is - disingenuous manipulator.

It's 'implied', in my opinion. If you are invested and we merge with Microsaic at this price, we get utterly fc uked. What part of that do you think may be a good thing.

And as usual he turns up, on cue, to pour as much cold water as he can muster, whilst selectively cherry-picking all of the points that paint as poor a picture as possible...

72p on a speculative, 'covid investor looking for short tern returns' SPIKE. 2 mins at 72p. I know, I was watching the price live.